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Adenovirus infection after stem cell transplantation is a significant cause of morbidity and
mortality, especially in children. A robust T-cell response induced by dendritic cells (DC) is crucial
for clearing the virus, suggesting their pivotal role for the response to human adenoviruses
(HAdV). Despite the widespread use of adenoviral vectors, the properties and kinetics of HAdV
infection of DC have not been addressed yet. We show that a recent clinical HAdV, subgenus
C/serotype 2 (strain BB2000-61), infects cells of the myeloid lineage. Infected DC produce early
and late viral antigens and show an altered expression of surface markers. Infection of monocytes
renders them refractory to differentiation into DC. Additionally, HAdV-infected DC are strong
stimulators of CD8
+ T cells. In summary, HAdV seems to manipulate the immune response by
infection of DC and possibly uses the infection of monocytes as a means to escape recognition by
T cells.
Human adenovirus (HAdV) frequently causes subclinical
infections and is additionally associated with acute
respiratory tract outbreak, epidemic kerato-conjunctivitis
and acute gastroenteritis. Life threatening systemic infec-
tions occur in immunosuppressed patients after allogeneic
stem cell transplantation (SCT) as well as solid organ
transplantation. Incidence of HAdV infection is highest in
children after allogeneic SCT. Risk factors are any cause of
severe T-cell deficiency post SCT, like T-cell depletion of
the graft, alternative donor SCT, delayed T-cell reconstitu-
tion and graft-versus-host-disease (Feuchtinger et al., 2007;
Howard et al., 1999; La Rosa et al., 2001; van Tol et al.,
2005). In contrast to the widespread use of adenovirus
(AdV) for gene therapy or vaccination trials (Samulski
et al., 1987), data on infection of immunologically relevant
cell types by clinical adenoviruses are sparse at best. It is yet
unknown how the interplay between the innate and
adaptive immune response is affected by HAdV, or how
antigen presenting cells are modulated by the infection.
Dendritic cells (DC) play a crucial role at the crossroad
between innate and adaptive immune response as they can
prime and activate T cells and modulate the type of T-cell
response. This makes them an attractive target for viruses
as many viruses are known to impair DC maturation and
function. Monocyte-derived DC (mdDC) have evolved as
an ideal cell type in order to study the effects of viral
infections, for example human cytomegalovirus (HCMV)
(Grigoleit et al., 2002; Jahn et al., 1999; Moutaftsi et al.,
2004; Raftery et al., 2001, 2009; Riegler et al., 2000). It was
thought until very recently that there were no data on the
susceptibility of DC for adenoviruses (Adams et al., 2009).
Langerhans cells and dermal DC express low levels of the
coxsackievirus and adenovirus receptor (CAR), while
mdDC lack this main receptor for the clinically most
relevant subgroup of HAdV, Ad5. HAdV overcomes this
limitation by using integrins as alternative entry receptors.
Additionally, it has now been demonstrated that lactoferrin
in association with DC-SIGN facilitates entry of recom-
binant HAdV5 into mdDC by mechanisms independent of
CAR (Adams et al., 2009).
Up to now there has not been any data about the
interactions of clinical HAdV strains with DC and their
capability to stimulate T cells. We investigated the
susceptibility of DC and their precursor cells for wild-type
adenovirus infection and analysed their T-cell stimulatory
capacity. We infected monocytes, immature and mature
mdDC with the clinical HAdV strain BB2000-61 (subgenus
C/serotype 2). We isolated BB2000-61 from the blood of an
SCT recipient (unpublished data). Subsequently, we
analysed the expression of distinct surface markers in
response to exposure to HAdV and finally tested the T-cell
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demonstrated that both monocytes and mdDC are
susceptible to an infection with a clinical HAdV strain.
The infection of immature mdDC resulted in an increased
expression of major histocompatibility complexes (MHC)
class I and class II, while expression of costimulatory
molecules was heterogeneous. When mature mdDC were
infected with BB2000-61, expression of MHC and costi-
mulatory molecules remained stable or decreased. The
infection of monocytes resulted in a block of differentiation
towards immature DC. Finally, BB2000-61-infected DC
stimulated CD8
+ T cells.
Up to now there has not been any publication as to
whether wild-type HAdV can infect DC. In order to
address this question, we inoculated immature mdDC with
BB2000-61. We analysed the replication of BB2000-61 and
an HAdV reference strain of subgenus C/serotype 5
(provided by A. Heim, Medizinische Hochschule
Hannover, Germany). DC were monocyte derived
(Grigoleit et al., 2002). In brief, peripheral blood mono-
nuclear cells (PBMC) were separated from buffy coats by
density-gradient centrifugation followed by CD14-based
magnetic positive-selection of monocytes. Monocytes were
used for experiments or incubated in six-well plates in
RPMI with 10% fetal calf serum, 100 mg gentamicin ml
21,
1000 U IL-4 ml
21 and 100 ng GM-CSF ml
21. After 7 days,
immature DC were rinsed off the plates and controlled
morphologically as well as for expression of CD1a, CD83,
MHC I, MHC II, CD80, CD86 and CD40. For infection
experiments, cells were incubated with different m.o.i.
amounts of strain BB2000-61 and further cultivated.
Thereafter, the cells were spun onto glass slides and stained
for viral early (E) and late (L) antigens. Monoclonal
antibodies (mAbs) were used directed against the E protein
E1A (ab33183; Abcam; IgG2a; Cambridge) and the L hexon
protein (C5000; Virion or Chemicon). Cytospins were
fixed in acetone for 10 min at room temperature and
incubated with the HAdV mAbs for 90 min at 37 uC,
followed by incubation with Cy3-conjugated F(ab)92
fragments of goat anti-mouse IgG antibodies (Jackson
ImmunoResearch). Finally, cells were counterstained with
4,6-diamidino-2-phenylindole (DAPI).
Primary monocytes were susceptible to infection with the
clinical HAdV strain as demonstrated by the expression of
the E and L genes (Fig. 1). Additionally, immature mdDC
could be infected with BB2000-61. When different m.o.i.
amounts were compared for the resulting efficiency of
infection, the percentage of infected cells ranged between 29
and 39% at an m.o.i. between 1 and 50 with a peak
efficiency of 39% at an m.o.i. of 10. The range was the same
for monocytes and mature mdDC. Intriguingly, higher
m.o.i. amounts did not result in higher efficiencies of
infection, but more cell debris was observed. The reference
strain was also able to infect mdDC and monocytes. Further
experiments were done with BB2000-61. This demonstrated
for the first time that DC are a target for a clinical HAdV
strain and both immature DC and their progenitors can be
infected. Additionally, the infection did not abort and both
the E and L proteins were expressed.
In order to assess if mature mdDC are also susceptible to
infection with HAdV, we added 1 mg LPS ml
21 or 10 mg
poly (I:C) (Sigma Aldrich) ml
21 after 7 days and
cultivated them for a further 24 h. This induced DC
maturation was demonstrated by upregulation of MHC
class I, class II, CD40, CD80, CD86 and CD83 expression
(data no shown). Mature DC were inoculated with
BB2000-61 as described for immature DC and cultivated
for a further 5 days. Mature mdDC had approximately the
same susceptibility as immature mdDC. This shows that
the myeloid lineage from monocytes to mature DC can be
a target for HAdV, and replication at least reaches the late
phase. The reference strain showed similar properties in
infectivity, but was not further included in flow cytometry
experiments/T-cell stimulation.
Many viruses are known to target DC and impair their
function in order to subvert adaptive immunity. For
example, HCMV infection impairs formation and intra-
cellular transport of MHC molecules, resulting in a
decreased surface expression of the respective molecules
(Beck et al., 2003; Grigoleit et al., 2002; Kessler et al., 2008;
Raftery et al., 2001; Tomazin et al., 1999). In order to assess
how a clinical HAdV strain acts in this regard, we
examined the surface expression of immunologically
relevant cell markers in mdDC after infection. To this
end immature mdDC were infected with BB2000-61 and
incubated for a further 5 days. Then the expression of
various surface markers was analysed. Cytometry was
performed using fluorescein isothiocyanate- or phycoery-
thrin-conjugated mAbs against surface markers: CD40
(Immunotech) and CD80, CD83, CD86, human leukocyte
antigen (HLA)-DR, CD14, HLA-A, -B and C (W6/32),
CD1a and IgG1 isotype control (Pharmingen). Infection of
immature mdDC with HAdV results in a rather hetero-
geneous immunophenotype as some markers were upre-
gulated, while others remained stable or were
downregulated. In detail, expression of MHC class I and
class II as CD86 increased, while CD80 was unaffected.
CD83 was slightly downregulated, while CD1a was strongly
reduced (Fig. 2a).
Manipulating the expression of functional surface markers
in infected DC is a known mechanism of viral immune
evasion (Grigoleit et al., 2002; Schneider et al., 2008).
While HCMV as a prominent example causes a somewhat
uniform downregulation of expression of both MHC and
costimulatory molecules, HAdV induces a more hetero-
geneous picture. Both MHC class I and class II are
upregulated as well as CD86 and CD40. All these molecules
are important for a successful interplay between DC and T
cells. On the other hand, infected mdDC show no
upregulation of CD83, a marker for mdDC maturation.
As mature mdDC were also susceptible to HAdV, we
analysed the immunophenotype. By impairing the surface
expression of MHC and costimulatory molecules, HAdV
HAdV infection of DC
http://vir.sgmjournals.org 1151Fig. 1. Expression of HAdV E and L antigens in
infected cells (strain BB2000-61). Expression
of E and L antigens was visualized 3 and 5 days
post-infection. Cells were either mock infected
or infected with BB2000-61. Mock is super-
natant from cells treated exactly as infected
ones except for the addition of HAdV. The m.o.i.
of 1 resulted in 31%, m.o.i. of 10 in 39%, m.o.i.
of 20 in 29% and m.o.i. of 50 in 31% positive-
stained immature DC with E1A-staining. E1A
antibody was diluted 1:100. Hexon specific
antibody was diluted 1:200. Secondary anti-
body, anti-mouse immunoperoxidase was
diluted 1:500. Counterstaining with DAPI.
Fig. 2. Expression of immunologically relevant surface markers after HAdV infection with an m.o.i. of 10. (a) Freshly isolated DC
were stained with antibodies specific for the designated markers or differentiated into mdDC by the addition of IL-4 and
GM-CSF and cultivation for 7 days, or infected with HAdV and cultivated for a further 7 days in the presence of IL-4 and
GM-CSF then stained and analysed by flow cytometry. (b) Freshly isolated monocytes were infected with the strain BB2000-61
and cultivated for a further 5 days. (c, d) Mature DC were infected with the same virus. The experiments were performed twice.
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even after the initial activation of the DC. Therefore, we
induced maturation of immature mdDC by the addition of
1 mg LPS ml
21 or 10 mg poly (I:C) (Sigma-Aldrich) ml
21.
Cells were further cultivated and infected with BB2000-61
as described above. Stimulation with LPS and poly (I:C)
resulted in an increased expression of MHC class II and a
more pronounced expression of CD80 and CD86.
Comparing the stimulatory performance, poly (I:C) was
superior to LPS. Nevertheless, when HAdV-infected
samples were compared with mock, HAdV infection
resulted in a decreased surface expression of CD80 and
CD86. Also, poly (I:C)-stimulated DC expression of MHC
class II was decreased, while it remained stable in LPS-
matured cells. Intriguingly, CD1a was expressed in higher
amounts on HAdV-infected LPS-matured DC than in poly
(I:C) stimulated ones.
LPS and poly (I:C) induce DC maturation by binding to
TLR4 and TLR3, respectively. While TLR4 is located on the
cell surface and common on many DC subsets, TLR3
resides in endosomes and is a unique feature of DC of the
myeloid lineage. The different pattern recognition recep-
tors, their localization and their signalling pathways
possibly are reflected in the variable response to LPS and
poly (I:C). Overall, maturation induced by poly (I:C)
seems to be more thorough as reflected by a stronger
upregulation of surface marker expression (Fig. 2c) and
additionally is permanent. After infection with HAdV, the
immunophenotype of mdDC matured with both LPS and
poly (I:C) is skewed to the level or below of immature
mdDC. The upregulation of MHC II and primarily CD80
and CD86 that accompanies DC maturation is reverted by
HAdV. The infection and subsequent manipulation of
mature DC could be one module of a multi-component
immune evasion strategy by HAdV. As immature DC
respond to HAdV infection with an upregulation of certain
activating molecules, formerly uninfected mature DC could
be impaired in their function. This would be especially
relevant for DC cross-presenting antigens without direct
contact to an antigen.
One important subtype of DC results from the differenti-
ation of monocytes into immature DC under the influence
of cytokines. As we demonstrated, monocytes are suscept-
ible to infection with a clinical HAdV strain. Infection of
the direct progenitor of the cell type that links innate and
adaptive immunity could be beneficial to a virus, since it
could modulate its differentiation process and function. To
test this assumption, we infected monocytes and added the
cytokines necessary for differentiation into immature
mdDC. After 7 days in culture (i.c.), we compared the
cells to both the freshly isolated monocytes and non-
infected cells with the same treatment regarding their
morphology and surface marker expression (Fig. 2b).
Viewed by microscope, monocytes appear as round bright
cells, while DC are less bright and feature their character-
istic shape. The majority of the HAdV-infected monocytes
remained as round and bright as freshly isolated monocytes
even after 7 days i.c., while a small fraction showed the
typical shape and colour of macrophages. When the freshly
isolated mock-infected monocytes were compared with
another fraction of the same monocytes that was
differentiated into mdDC, the latter showed all signs of
differentiation: CD1a, MHC class II, CD80, CD86 and
CD40 expression was upregulated, while CD14 expression
was almost diminished. In contrast, HAdV-infected cells
showed no signs of differentiation into DC. CD1a, MHC
class II, CD80, CD86 and CD40 expression were down-
regulated, with the exception of CD86 even below the level
expressed by monocytes without cytokine stimulation.
Additionally, expression of CD14 was increased above
monocyte level. All these data, together with the morpho-
logical observation, demonstrate that HAdV-infected
monocytes cannot be differentiated into immature DC
despite stimulation by IL-4 and GM-CSF.
DC are crucial for the induction of an adaptive immune
response to viral infection. One of the DC subtypes, the
mdDC directly differentiates from monocytes in the
appropriate cytokine milieu. By the infection of this
progenitor cell, HAdV is able to block differentiation to
immature DC, thereby probably blocking the presentation
of HAdV-derived antigens by these cells. Together with the
potential to infect mature DC followed by a decreased
expression of immunological activating surface markers,
this could overcome the inability to impair expression of
MHC and costimulatory molecules in HAdV-infected
immature DC.
The ability to induce T-cell activation and proliferation is a
hallmark of DC function. This ability summarizes all
singular features like expression of MHC and costimula-
tory molecules, acquiring, processing and displaying
antigens and secreting cytokines. Therefore, the success of
viral subversion of DC function has to be measured by the
virus’ capability to evade T-cell proliferation. In order to
assess the effect of adenoviral infection of mdDC on their
Fig. 3. Stimulation of autologous T cells detected by CFSE.
HAdV-infected DC were irradiated and co-cultured with auto-
logous PBMC. Mock-infected DC stimulated 0.57% of the
autologous cytotoxic T cells to proliferate, while HAdV-infected
mdDC induced an increase in proliferation to 5.44%. Analysis of
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lymphocyte reaction. DC were irradiated and co-cultured
with autologous PBMC. After restimulation with inacti-
vated viral particles, in vitro proliferation was detected with
carboxyfluorescein succinimidyl ester (CFSE) (Feuchtinger
et al., 2008). Mock-infected DC stimulated 0.57% of the
autologous CD8
+ T cells to proliferate, while direct
stimulation of T cells with staphylococcus enterotoxin B
resulted in a proliferation of 33% of the CD8
+ T cells.
When HAdV-infected mdDC were incubated with the cells,
5.44% of them proliferated (Fig. 3). This shows that the
adenoviral infection of DC does not result in a block of
CD8
+ T-cell stimulation as can be seen in other viruses
with similar impact on immune response. In comparison,
HCMV leads to a remarkable decrease of the T-cell
stimulatory capacity of infected DC (Grigoleit et al.,
2002; S. Schempp, personal communication). In contrast
to this betaherpesvirus, HAdV-infected DC are still able to
stimulate CD8
+ T cells and thereby induce a cellular
immune response.
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